会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 81. 发明申请
    • Fuel Cell
    • 燃料电池
    • US20070264555A1
    • 2007-11-15
    • US11663929
    • 2005-11-16
    • Tsunemasa NishidaToshiyuki SuzukiTsutomu OchiNaohiro TakeshitaHiroo Yoshikawa
    • Tsunemasa NishidaToshiyuki SuzukiTsutomu OchiNaohiro TakeshitaHiroo Yoshikawa
    • H01M8/02
    • H01M8/026H01M2250/20Y02T90/32
    • A fuel cell including separators opposing each other and squeezing a power generating reaction portion. Each of the separators includes a gas passage, a gas passage dividing rib, and a protrusion formed in the gas passage. In a first separator, which is an at least one separator of the separators opposing each other via the power generating reaction portion, at a region of the first separator opposing a gas passage dividing rib of a second separator, which is a separator opposing the first separator, a squeezing rib is formed and replaces the protrusion. The squeezing rib and the gas passage dividing rib of the second separator squeezes the power generating reaction portion. At the region of the first separator, a contact area of the squeezing rib with the power generating reaction portion is adapted to be larger than a contact area of the protrusion of the first separator with the power generating reaction portion in a case where the protrusion were formed without forming the squeezing rib.
    • 一种燃料电池,包括彼此相对的并且挤压发电反应部分的隔板。 每个分离器包括气体通道,气体通道分隔肋和形成在气体通道中的突起。 在通过发电反应部分彼此相对的分离器的至少一个分离器的第一分离器中,在第一分离器的与第二分离器的气体通道分隔肋相对的区域处,第二分离器是与第一分离器相对的分隔件 分离器,形成挤压肋并代替突起。 第二分离器的挤压肋和气体通道分隔肋挤压发电反应部。 在第一分离器的区域,挤压肋与发电反应部分的接触面积适于大于第一分离器的突起与发电反应部分的接触面积, 形成而不形成挤压肋。
    • 88. 发明授权
    • Heterocycle derivatives and drugs
    • 杂环衍生物和药物
    • US06787546B2
    • 2004-09-07
    • US10149622
    • 2002-06-12
    • Toshiyuki SuzukiTomiyoshi Aoki
    • Toshiyuki SuzukiTomiyoshi Aoki
    • A61K3144
    • C07D213/42C07D213/89
    • The object of the invention is to provide an excellent compound as a drug. The invention relates to a heterocyclic compound shown by the following formula: A—B—D—E  [1] wherein A is heteroaryl or its oxide; B is ethenylene; D is optionally substituted phenylene; and E is a group of the formula:  wherein G is optionally substituted phenyl; and R is heteroaryl or heteroarylmethyl, or a group of the formula: wherein n is an integer of 1 to 5; R5 and R6 are same or different and are independently selected from the group consisting of hydrogen, C1—C6 alkyl, hydroxyalkyl, aminoalkyl; or R5 and R6 taken together with the adjacent nitrogen atom may form 5- to 7-membered cyclic amino group for —NR5R6 or a salt thereof.
    • 本发明的目的是提供作为药物的优异的化合物。本发明涉及下式所示的杂环化合物:其中A是杂芳基或其氧化物; B是亚乙烯基; D是任选取代的亚苯基; 和E是下式的基团:其中G是任选取代的苯基; R是杂芳基或杂芳基甲基,或下式的基团:其中n是1至5的整数; R 5和R 6相同或不同,并且独立地选自氢,C 1 -C 6烷基,羟基烷基,氨基烷基; 或R 5和R 6与相邻氮原子一起可以形成-NR 5 R 6的5-至7-元环氨基或其盐。